Advita Ortho Acquires Bauer Innovations’ Shoulder Arthroplasty IP

Advita Ortho has obtained three novel IP applications from Bauer Innovations to grow its Equinoxe shoulder system portfolio.

The Gainsville, Florida-based company said this expands the its ability to treat patients with glenoid bone loss using reverse total shoulder arthroplasty (rTSA). It plans to use these patents to develop reverse shoulder glenoid baseplates that improve fixation in revision shoulder arthroplasty patients with central vault and uncontained glenoid defects.

Last week, Advita announced the first clinical use of reverse shoulder humeral liners manufactured with its Activit-E vitamin E polyethylene for the Equinoxe reverse shoulder system.

Comments from Advita Ortho and Bauer Innovations

Chris Roche, Advita’s senior VP of Extremities: “This important acquisition will help expand Advita’s portfolio of innovative Equinoxe Shoulder System solutions, allowing us to develop a next-generation rTSA glenoid revision baseplate system that enables surgeons to treat their most difficult glenoid bone loss patients in a more efficient manner. This investment facilitates development of a revision rTSA glenoid baseplate that will be able to address practically any size or shape glenoid defect, using an off-the-shelf component.”

Greg Bauer, MD, Bauer Innovations: “Bauer Innovations and I share Advita’s vision for a comprehensive solution for glenoid defects encountered during revision surgery. My experience during these procedures inspired the development of the intellectual property; I felt we needed something between standard implants with bone grafts and custom implants. I am proud of what Bauer Innovations developed, and we are excited to continue that work with Advita and utilize this intellectual property to commercialize a novel revision glenoid system that will help surgeons treat their most challenging patients with glenoid bone loss.”